Dronedarone Tablets Guide: Uses, Dosage, Side Effects
Comprehensive guide to Dronedarone (Multaq) tablets: uses, dosage, side effects, and precautions for managing atrial fibrillation.
Dronedarone, marketed as Multaq, is an antiarrhythmic medication designed to reduce the risk of hospitalization due to atrial fibrillation (AF) in patients currently in normal sinus rhythm with a history of paroxysmal or persistent AF. It works by slowing nerve impulses in the heart tissue to help maintain a regular heartbeat.
About dronedarone tablets
Dronedarone belongs to the class III antiarrhythmic drugs and is structurally similar to amiodarone but with modifications to reduce organ toxicity risks, such as thyroid and pulmonary issues. Approved by the FDA in 2009, it is indicated for patients in sinus rhythm who have experienced paroxysmal or persistent AF in the past. Unlike amiodarone, dronedarone has a shorter half-life (13-19 hours) and lower tissue accumulation, making it suitable for long-term use in select patients.
The medication is available only by prescription in tablet form, typically 400 mg strength. It directly affects heart tissue by blocking multiple ion channels, including potassium, sodium, and calcium channels, which helps restore and maintain normal sinus rhythm.
Key facts about dronedarone tablets
- Brand name: Multaq
- Type of medicine: Class III antiarrhythmic
- Used for: Reducing hospitalization risk for AF in sinus rhythm patients with AF history
- Dosage: 400 mg twice daily with meals
- Available as: Tablets (400 mg)
- Half-life: 13-19 hours; steady-state reached in 4-8 days
- Not suitable for: Patients with decompensated heart failure, permanent AF, or certain conduction abnormalities
When to take dronedarone tablets
The recommended dose is 400 mg twice daily, taken orally with the morning and evening meals to enhance absorption. Food increases bioavailability by approximately 2-4 times. Steady-state plasma levels are achieved within 4-8 days, with moderate accumulation (ratio 2.6-4.5). Peak concentrations occur 3-6 hours post-dose.
Do not exceed the prescribed dose. If a dose is missed, take it as soon as remembered unless close to the next dose; do not double up. Treatment should be initiated only in patients in sinus rhythm, with regular ECG monitoring every 3 months to detect AF recurrence.
How to take dronedarone tablets
Swallow tablets whole with a full glass of water, always with food. Avoid grapefruit juice or strong CYP3A inhibitors, as they can increase dronedarone levels significantly. Prior to starting, discontinue other Class I or III antiarrhythmics for 2-4 half-lives. No dosage adjustment needed for mild-moderate renal impairment, but monitor function periodically.
- Take with breakfast and dinner
- Do not crush or chew tablets
- Store at room temperature, away from moisture
Who can and cannot take dronedarone tablets
Dronedarone is suitable for adults in sinus rhythm with AF history, without permanent AF or NYHA Class IV heart failure. It is contraindicated in:
- Patients with symptomatic heart failure with recent decompensation or NYHA Class IV (doubles death risk)
- Permanent AF (increased risk of death, stroke, heart failure)
- Second- or third-degree AV block or sick sinus syndrome (unless pacemaker present)
- Bradycardia <50 bpm
- Concomitant strong CYP3A4 inhibitors (e.g., ketoconazole)
- Pregnancy, breastfeeding, or severe hepatic impairment
Use caution in elderly, females (30% higher exposure), or those with renal impairment.
How and when to take dronedarone tablets
Administer 400 mg BID with meals. Therapeutic plasma levels build over days. In trials like ATHENA, maximum follow-up was 30 months, showing reduced AF hospitalization. Monitor heart rhythm frequently; cardiovert if AF develops or discontinue.
Dosage
Standard adult dose: 400 mg orally twice daily. No pediatric dosing. Adjust or discontinue if QTc prolongs >500 ms, creatinine rises >50%, or liver enzymes exceed 3x ULN. Small creatinine increases (0.1 mg/dL) are common due to tubular secretion inhibition and reversible.
| Patient Group | Dosage | Notes |
|---|---|---|
| Adults | 400 mg BID with meals | Monitor ECG, renal, liver q3 months |
| Renal Impairment (mild-moderate) | No adjustment | Monitor CrCl |
| Hepatic Impairment (severe) | Contraindicated | – |
| Elderly | 400 mg BID | Higher exposure; caution |
Side effects of dronedarone tablets
Common side effects (≥5%): diarrhea (9%), nausea (3-5%), abdominal pain (3%), vomiting (2%), asthenia (4%). In trials, 11.8% discontinued due to adverse events vs. 7.7% placebo; GI issues most frequent (3.2%).
Serious risks:
- Heart failure/death: Doubles risk in decompensated HF or permanent AF
- QT prolongation: Dose-related (+10 ms at 400 mg BID); torsades risk with hypokalemia
- Liver injury: Rare hepatocellular damage; monitor ALT/AST
- Bradycardia, renal effects: Reversible Cr rise
Report severe diarrhea, weakness, chest pain, or jaundice immediately. Full list in prescribing info.
Pregnancy and breastfeeding with dronedarone tablets
Contraindicated in pregnancy (Category X); potential fetal harm via ion channel effects. Animal studies show embryotoxicity. Effective contraception required; discontinue if pregnant. Unknown if excreted in breast milk—do not breastfeed.
Other medicines, food, and alcohol
Dronedarone is metabolized by CYP3A4; moderate inhibitor of CYP3A/CYP2D6. Avoid:
- Strong CYP3A inhibitors (ketoconazole, ritonavir)—contraindicated
- QT-prolonging drugs (class I/III antiarrhythmics, beta-blockers)
- Potassium-depleting diuretics (hypokalemia risk)
- Grapefruit juice (increases levels)
Alcohol may exacerbate AF; limit intake. Inform doctor of all medications.
Cautions of dronedarone tablets
Monitor cardiac rhythm q3 months; discontinue if permanent AF. Baseline and periodic ECG, renal/liver function tests. Increased stroke risk early in permanent AF. Higher exposure in females, moderate renal impairment.
Common questions about dronedarone tablets
How long should you take dronedarone?
Long-term as long as benefits outweigh risks; reassess periodically with ECG monitoring.
Can you stop taking dronedarone suddenly?
Consult doctor; abrupt stop may increase AF risk. Taper if needed.
Does dronedarone affect blood pressure?
May cause bradycardia; monitor BP and HR.
Can you take dronedarone with beta-blockers?
Use caution; additive bradycardia/QT effects. Monitor closely.
Is dronedarone better than amiodarone?
Similar efficacy with fewer toxicities; designed as safer alternative.
About atrial fibrillation
AF is irregular heartbeat increasing stroke/heart failure risk. Dronedarone reduces hospitalization in non-permanent cases by maintaining sinus rhythm. Risk factors: age, hypertension, heart disease.
References
- Dronedarone (oral route) – Mayo Clinic — Mayo Clinic. 2023. https://www.mayoclinic.org/drugs-supplements/dronedarone-oral-route/description/drg-20073151
- MULTAQ (dronedarone) Tablets Prescribing Information — FDA. 2014-01-24. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022425s025lbl.pdf
- Dronedarone: Uses, Interactions, Mechanism of Action — DrugBank. 2023. https://go.drugbank.com/drugs/DB04855
- MULTAQ Prescribing Information — Sanofi. 2023. https://products.sanofi.us/multaq/multaq.pdf
- MULTAQ (dronedarone) 400mg Tablets | HCP — Sanofi. 2023. https://pro.campus.sanofi/us/products/multaq
Similar Articles
Read full bio of medha deb
